In a communication system comprising a gateway node between a communication network 1 and a circuit-switched communication network 2 via a plurality of circuit-switched channels ch 1,. Compositions may comprise one or more ovarian tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. The method can be readily extended to remove inhibitory compounds from hydrolysate.